Santhera Pharmaceuticals Holding Stock Price on February 23, 2023
SPHDF Stock | USD 9.42 0.00 0.00% |
If you're considering investing in Santhera Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Santhera Pharmaceuticals stands at 9.42, as last reported on the 23rd of January, with the highest price reaching 9.42 and the lowest price hitting 9.42 during the day. Santhera Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13 % return per unit of risk over the last 3 months. Santhera Pharmaceuticals Holding exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Santhera Pharmaceuticals' Variance of 5.75, coefficient of variation of (812.40), and Risk Adjusted Performance of (0.1) to confirm the risk estimate we provide.
Santhera Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Santhera |
Sharpe Ratio = -0.1302
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SPHDF |
Estimated Market Risk
2.54 actual daily | 22 78% of assets are more volatile |
Expected Return
-0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Santhera Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Santhera Pharmaceuticals by adding Santhera Pharmaceuticals to a well-diversified portfolio.
Related Headline
MeiraGTx Holdings Headline on 23rd of February 2023
Acquisition by Stuart Naylor of 100000 shares of MeiraGTx Ho... by Stuart Naylor
Filed transaction by Meiragtx Holdings Plc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Santhera Pharmaceuticals Valuation on February 23, 2023
It is possible to determine the worth of Santhera Pharmaceuticals on a given historical date. On February 23, 2023 Santhera was worth 1.2 at the beginning of the trading date compared to the closed value of 1.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Santhera Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Santhera Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Santhera Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Santhera Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
1.20 | 1.20 | 1.20 | 1.20 | 1.00 | |
02/23/2023 | 1.20 | 1.20 | 1.20 | 1.20 | 1.00 |
1.20 | 1.20 | 1.20 | 1.20 | 1.00 |
Backtest Santhera Pharmaceuticals | | | Santhera Pharmaceuticals History | | | Santhera Pharmaceuticals Valuation | Previous | Next |
Santhera Pharmaceuticals Trading Date Momentum on February 23, 2023
On February 24 2023 Santhera Pharmaceuticals Holding was traded for 1.20 at the closing time. The highest daily price throughout the period was 1.20 and the lowest price was 1.20 . There was no trading activity during the period 1.0. Lack of trading volume on 02/24/2023 did not result in any price rise and fall. The trading price change to current closing price is 0.00% . |
Santhera Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Santhera Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Santhera Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Santhera financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Santhera Pharmaceuticals Pink Sheet history
Santhera Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Santhera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Santhera Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Santhera Pharmaceuticals stock prices may prove useful in developing a viable investing in Santhera Pharmaceuticals
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland. SANTHERA PHARMACEUTICALS operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs people.
Santhera Pharmaceuticals Pink Sheet Technical Analysis
Santhera Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Santhera Pharmaceuticals Period Price Range
Low | January 23, 2025
| High |
0.00 | 0.00 |
Santhera Pharmaceuticals Holding cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Santhera Pharmaceuticals January 23, 2025 Market Strength
Market strength indicators help investors to evaluate how Santhera Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Santhera Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Santhera Pharmaceuticals pink sheet market strength indicators, traders can identify Santhera Pharmaceuticals Holding entry and exit signals to maximize returns
Santhera Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Santhera Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Santhera Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Santhera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.1) | |||
Jensen Alpha | (0.31) | |||
Total Risk Alpha | (0.38) | |||
Treynor Ratio | (1.23) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Santhera Pink Sheet analysis
When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
CEOs Directory Screen CEOs from public companies around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |